Skip to content

Nutritional status and inflammatory profile of patients with cancer of the oral cavity in pre-antineoplastic treatment (Chemotherapy/Radiotherapy/Surgery) before and after nutritional supplementation.

Nutritional status and inflammatory profile of patients with cancer of the oral cavity in pre-antineoplastic treatment (Chemotherapy/Radiotherapy/Surgery) before and after nutritional supplementation.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-25zmjm
Enrollment
Unknown
Registered
2016-04-25
Start date
2015-02-23
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neoplasm oral cavity, nutritional status, cachexia

Interventions

The patients will go through a sorting, and if they are classified as malnourished or at nutritional risk and if they meet the criteria of inclusion, will be invited to participate in the study, by ex
Dietary supplement
SP6.051.227

Sponsors

Instituto Nacional de Câncer
Lead Sponsor
Instituto Nacional de Câncer
Collaborator

Eligibility

Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were patients who were referred to the Outpatient Clinic of nutrition in pre-antineoplastic treatment (chemotherapy/radiotherapy/surgery) with cancer of the oral cavity enrolled at the National Institute of Cancer, age between 40 to 75 years, malnutrition or nutritional risk, and agreed to participate in the study by signing the Free and Informed Consent Term after being informed about the reasons for the study and collaboration that is expected of them.

Exclusion criteria

Exclusion criteria: Exclusion criteria were diabetes mellitus, liver disease, renal disease, treatment with radiotherapy or chemotherapy already started or has already performed at another time.

Design outcomes

Primary

MeasureTime frame
The weight gain in a period of four weeks, verified by measurement of weight pre and post intervention, in digital scale, from a variation of at least one kilo between the measures.

Secondary

MeasureTime frame
The gain of lean mass in the period of 4 weeks, verified by bioimpedance in pre and post intervention, from a variation of 3% between the measures.

Countries

Brazil

Contacts

Public ContactThayana de Carvalho

Instituto Nacional de Câncer

thayanacalixto@hotmail.com+55 (21) 98839 2546

Outcome results

None listed

Source: REBEC (via WHO ICTRP)